Literature DB >> 19185652

Established, emerging and future roles of PET/CT in the management of colorectal cancer.

R A Herbertson1, A F Scarsbrook, S T Lee, N Tebbutt, A M Scott.   

Abstract

Positron-emission tomography-computed tomography (PET/CT) is rapidly being integrated into the imaging pathways of several different tumour types, most frequently using the glucose analogue 2- [(18)F]-fluoro-2-deoxy-D-glucose (FDG). Integrated FDG-PET/CT combines functional and anatomical imaging to improve sensitivity and specificity of tumour detection. The aim of this article is to review the established, emerging, and future roles of FDG-PET/CT in the management of patients with colorectal cancer (CRC).

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19185652     DOI： 10.1016/j.crad.2008.08.008

Source DB:  PubMed          Journal:  Clin Radiol        ISSN： 0009-9260            Impact factor:   2.350


  19 in total

1.  Combined Positron Emission Tomography and Computed Tomography: Option or necessity?

Authors:  Naima K Al-Bulushi
Journal:  Sultan Qaboos Univ Med J       Date:  2015-01-21

2.  [Importance of PET/CT for imaging of colorectal cancer].

Authors:  F G Meinel; N Schramm; A R Haug; A Graser; M F Reiser; C Rist
Journal:  Radiologe       Date:  2012-06       Impact factor: 0.635

Review 3.  Personalized colon cancer care in 2010.

Authors:  Daniel V T Catenacci; Mark Kozloff; Hedy L Kindler; Blase Polite
Journal:  Semin Oncol       Date:  2011-04       Impact factor: 4.929

4.  Long-Term Outcomes and Lymph Node Metastasis in Patients Receiving Radical Surgery for Pathological T1 Lower Rectal Cancer.

Authors:  Daichi Kitaguchi; Takeshi Sasaki; Yuji Nishizawa; Yuichiro Tsukada; Masaaki Ito
Journal:  World J Surg       Date:  2019-02       Impact factor: 3.352

Review 5.  A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner?

Authors:  Astrid Langer
Journal:  BMC Health Serv Res       Date:  2010-10-08       Impact factor: 2.655

6.  Correlation of tissue biopsy and fine needle aspiration cytology with positron emission tomography results.

Authors:  Daniel Rosen; Bruce Herrington; Peeyush Bhargava; Rodolfo Laucirica; Gordana Verstovsek
Journal:  Patholog Res Int       Date:  2011-04-06

7.  Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method.

Authors:  Rafke Schoffelen; Winette Ta van der Graaf; Robert M Sharkey; Gerben M Franssen; William J McBride; Chien-Hsing Chang; Peter Laverman; David M Goldenberg; Wim Jg Oyen; Otto C Boerman
Journal:  EJNMMI Res       Date:  2012-01-27       Impact factor: 3.138

Review 8.  Positron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected Review.

Authors:  Alberto Zaniboni; Giordano Savelli; Claudio Pizzocaro; Pietro Basile; Valentina Massetti
Journal:  Gastroenterol Res Pract       Date:  2015-05-11       Impact factor: 2.260

9.  Combination therapy of anti-cancer bioactive peptide with Cisplatin decreases chemotherapy dosing and toxicity to improve the quality of life in xenograft nude mice bearing human gastric cancer.

Authors:  Xiulan Su; Chao Dong; Jialing Zhang; Liya Su; Xuemei Wang; Hongwei Cui; Zhong Chen
Journal:  Cell Biosci       Date:  2014-02-10       Impact factor: 7.133

10.  Correlation of intra-tumor 18F-FDG uptake heterogeneity indices with perfusion CT derived parameters in colorectal cancer.

Authors:  Florent Tixier; Ashley M Groves; Vicky Goh; Mathieu Hatt; Pierre Ingrand; Catherine Cheze Le Rest; Dimitris Visvikis
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.